Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2019 | The need for patient advocates to attend major congresses such as EBMT

Jan Geissler • 24 Mar 2019
EBMT 2019
General

Jan Geissler, Dipl, from Patvocates GmbH, Hohenbrunn, Germany, speaks at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany. Mr Geissler gives an overview of why patient advocates should be attending major congresses such as the EBMT annual meeting. Patient advocates can be inundated with the latest clinical updates, potential therapies and their risks, which can be passed on to the patient community.

More from Jan Geissler

1:14
The evolution of patient advocacy
Jan Geissler • 24 Mar 2019
1:28
The importance of patient advocacy tracks at congresses
Jan Geissler • 24 Mar 2019
0:53
The aims of the Patvocates Network
Jan Geissler • 24 Mar 2019
2:38
Understanding science and research: the importance of patient advocates
Jan Geissler • 22 Jun 2017

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals